As of May 2026, MVIC had a new board constellation with two new board members. The new board members are Charlott Brunmark, CSO at the MVIC member company Truly Labs, and Roger Lassing, CEO at Sapiens Lassing. Both have a long experience in the pharmaceutical industry and will contribute to the development of MVIC with their expert knowledge. Carl-Johan Gustafson continues as chairman of the board. The board members Martin Lindsjö, at MVIC member company Magle Chemoswed, and Ann Tronde, at Region Skåne, have also been re-elected. We thank the two board members, Gunilla Petersson and Per-Ola Önnervik, for their time and engagement as they now have left their posts as MVIC board members.